Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PemSplitCisp: Split-dose Cisplatin + Pemetrexed in NSCLC
NCT01742767Phase 2Unknown
- Sponsor
- University of Duisburg-Essen
- Start
- Nov 2012
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin in Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC), sponsored by University of Duisburg-Essen. Status: unknown.
02
Drugs
cisplatin
03
Conditions
Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC)
Beyond the preview
Go deeper on NCT01742767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01742767.